Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia

BACKGROUND: Risperidone is a commonly prescribed antipsychotic drug with a potential side effect of weight gain. However, the pathophysiological mechanism is still poorly understood. Here, we sought to identify potential biomarkers of risperidone-induced weight gain by using a targeted metabolomics...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Yuying, Dong, Yeqing, Sun, Wei, Li, Gang, Li, Mei Juan, Zhao, Yongping, Jiang, Changyong, Li, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171109/
https://www.ncbi.nlm.nih.gov/pubmed/37181896
http://dx.doi.org/10.3389/fpsyt.2023.1144873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171109/
https://www.ncbi.nlm.nih.gov/pubmed/37181896
http://dx.doi.org/10.3389/fpsyt.2023.1144873

Ejemplares similares